You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for Patent: 6,395,888


✉ Email this page to a colleague

« Back to Dashboard


Title: High affinity nucleic acid ligands of complement system proteins
Abstract:Methods are described for the identification and preparation of high-affinity Nucleic Acid Ligands to Complement System Proteins. Methods are described for the identification and preparation of high affinity Nucleic Acid Ligands to Complement System Proteins C1q, C3 and C5. Included in the invention are specific RNA ligands to C1q, C3 and C5 identified by the SELEX method.
Inventor(s): Biesecker; Gregory (Boulder, CO), Gold; Larry (Boulder, CO)
Assignee: Gilead Sciences, Inc. (Foster City, CA)
Filing Date:Sep 29, 1998
Application Number:09/163,025
Claims:1. A purified and isolated non-naturally occurring Nucleic Acid Ligand to C5, wherein said ligand is an RNA ligand selected from the group consisting of SEQ ID NOS: 75, 160-196.

2. The Nucleic Acid Ligand of claim 1 wherein said ligand is substantially homologous to and has substantially the same ability to bind said C5 as a ligand selected from the group consisting of SEQ ID NOS: 75, 160-196.

3. The Nucleic Acid Ligand of claim 1 wherein said ligand has substantially the same structure and has substantially the same ability to bind said C5 as a ligand selected from the group consisting of SEQ ID NOS: 75, 160-196.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.